Takahiko Saida

5.9k total citations
130 papers, 3.7k citations indexed

About

Takahiko Saida is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Takahiko Saida has authored 130 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pathology and Forensic Medicine, 46 papers in Neurology and 25 papers in Immunology. Recurrent topics in Takahiko Saida's work include Multiple Sclerosis Research Studies (51 papers), Peripheral Neuropathies and Disorders (41 papers) and Hereditary Neurological Disorders (19 papers). Takahiko Saida is often cited by papers focused on Multiple Sclerosis Research Studies (51 papers), Peripheral Neuropathies and Disorders (41 papers) and Hereditary Neurological Disorders (19 papers). Takahiko Saida collaborates with scholars based in Japan, United States and United Kingdom. Takahiko Saida's co-authors include Kyoko Saida, Donald H. Silberberg, Mark J. Brown, Shigekazu Kuroki, Austin J. Sumner, Arthur K. Asbury, Robert P. Lisak, D. H. Silberberg, Margaret C. Manning and Makoto Matsui and has published in prestigious journals such as Nature, Science and The Journal of Immunology.

In The Last Decade

Takahiko Saida

127 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiko Saida Japan 32 1.9k 1.3k 971 623 591 130 3.7k
H. Link Sweden 26 1.0k 0.5× 347 0.3× 1.0k 1.1× 779 1.3× 549 0.9× 59 3.0k
Michiaki Koga Japan 41 4.1k 2.1× 3.2k 2.5× 355 0.4× 448 0.7× 403 0.7× 187 5.6k
Martina Deckert Germany 45 2.3k 1.2× 367 0.3× 2.5k 2.6× 1.6k 2.5× 1.2k 2.1× 150 6.4k
M. C. Dal Canto United States 29 730 0.4× 267 0.2× 552 0.6× 1.1k 1.7× 650 1.1× 53 3.1k
Sérgio Ferrari Italy 33 1.7k 0.9× 599 0.5× 452 0.5× 178 0.3× 1.8k 3.1× 170 4.2k
Corinna Trebst Germany 38 1.4k 0.7× 400 0.3× 2.1k 2.1× 1.5k 2.4× 795 1.3× 86 5.4k
William Sheremata United States 31 810 0.4× 198 0.2× 1.4k 1.5× 1.3k 2.2× 624 1.1× 68 3.5k
Kazim A. Sheikh United States 32 2.1k 1.1× 2.0k 1.5× 188 0.2× 295 0.5× 589 1.0× 73 3.6k
Scott Dessain United States 21 2.3k 1.2× 677 0.5× 232 0.2× 468 0.8× 2.5k 4.2× 53 6.6k
Mauro C. Dal Canto United States 35 4.0k 2.1× 991 0.8× 994 1.0× 2.5k 4.0× 2.2k 3.7× 85 9.6k

Countries citing papers authored by Takahiko Saida

Since Specialization
Citations

This map shows the geographic impact of Takahiko Saida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiko Saida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiko Saida more than expected).

Fields of papers citing papers by Takahiko Saida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiko Saida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiko Saida. The network helps show where Takahiko Saida may publish in the future.

Co-authorship network of co-authors of Takahiko Saida

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiko Saida. A scholar is included among the top collaborators of Takahiko Saida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiko Saida. Takahiko Saida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujihara, Kazuo, Ho Jin Kim, Takahiko Saida, et al.. (2023). Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study. Multiple Sclerosis and Related Disorders. 79. 104938–104938. 5 indexed citations
2.
Saida, Takahiko, Takashi Yamamura, Takayuki Kondo, et al.. (2019). A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries. BMC Neurology. 19(1). 5–5. 22 indexed citations
3.
Saida, Takahiko, Yasuto Itoyama, Seiji Kikuchi, et al.. (2017). Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study. BMC Neurology. 17(1). 17–17. 19 indexed citations
4.
5.
6.
Tanaka, Masami, et al.. (2016). Neuromyelitis optica patient relapsed after 9 years with seroreversion of anti‐aquaporin 4 antibodies. Clinical and Experimental Neuroimmunology. 8(1). 47–48. 1 indexed citations
7.
Saida, Takahiko. (2004). First Regional MS Forum Meeting raises MS awareness and highlights questions. The MS Forum Pan-Asian Conference, 912 October 2003, Bangkok, Thailand.. PubMed. 11(1). 32–3. 2 indexed citations
8.
Nishimura, Mayumi, Shigekazu Kuroki, Masafumi Nukina, et al.. (1998). Genetic contribution of the tumor necrosis factor region in guillain‐barré syndrome. Annals of Neurology. 44(5). 815–818. 28 indexed citations
9.
Hao, Qi, Takahiko Saida, Shigekazu Kuroki, et al.. (1998). Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections. Journal of Neuroimmunology. 81(1-2). 116–126. 77 indexed citations
10.
11.
Maruyama, Hirofumi, Hideshi Kawakami, Tatsuo Kohriyama, et al.. (1997). CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification. Journal of the Neurological Sciences. 152(2). 166–171. 18 indexed citations
12.
Kawakami, Hideshi, Hirofumi Maruyama, Michio Yasunami, et al.. (1996). Cloning and Expression of a Rat Brain Basic Helix–Loop–Helix Factor. Biochemical and Biophysical Research Communications. 221(1). 199–204. 11 indexed citations
13.
Nishimura, Masataka, et al.. (1996). PCR-based restriction fragment length polymorphism (RFLP) analysis and serotyping ofCampylobacter jejuniisolates from diarrheic patients in China and Japan. FEMS Microbiology Letters. 142(2-3). 133–138. 20 indexed citations
14.
Saida, Kyoko, Mitsuhiro Ohta, Hideshi Kawakami, & Takahiko Saida. (1996). Cytokines and myelin antibodies in Crow-Fukase syndrome. Muscle & Nerve. 19(12). 1620–1622. 5 indexed citations
15.
Saida, Takahiko, Kyoko Saida, Masanori Funauchi, et al.. (1987). HTLV-I encephalomyelitis — isolation of virus and infection in neural cell lines. Journal of Neuroimmunology. 16(1). 152–152. 2 indexed citations
16.
Saida, Takahiko, et al.. (1986). Role of nonspecific myelin destruction by delayed type hypersensitivity in primary demyelination. Journal of the Neurological Sciences. 74(1). 97–109. 9 indexed citations
17.
Nakao, Yoshinobu, Shuichi Matsuda, Nobuhisa Kobayashi, et al.. (1983). Teleocidin-Induced Phenotypic Changes in Thymic ALL Cell Line, HPB-ALL. Oncology. 40(4). 273–279. 1 indexed citations
18.
Saida, Takahiko, et al.. (1980). A new assay for lytic anti-galactocerebroside (GC) antibodies employing 56rubidium release from GC-labelled liposomes. Journal of Immunological Methods. 39(1-2). 31–38. 5 indexed citations
19.
Saida, Kyoko, Takahiko Saida, Mark J. Brown, D. H. Silberberg, & Arthur K. Asbury. (1978). Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum.. PubMed. 39(5). 449–62. 83 indexed citations
20.
Pleasure, David, et al.. (1977). Lipid synthesis by an oligodendroglial fraction in suspension culture. Brain Research. 134(2). 377–382. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Link Breakdown of academic impact, for papers by Michiaki Koga Breakdown of academic impact, for papers by Martina Deckert Breakdown of academic impact, for papers by M. C. Dal Canto Breakdown of academic impact, for papers by Sérgio Ferrari Breakdown of academic impact, for papers by Corinna Trebst Breakdown of academic impact, for papers by William Sheremata Breakdown of academic impact, for papers by Kazim A. Sheikh Breakdown of academic impact, for papers by Scott Dessain Breakdown of academic impact, for papers by Mauro C. Dal Canto
Rankless by CCL
2026